Cargando...
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
With the event of new Molecular targets, clinical trial design requirements to perform these trials are changing. This paper discusses some of the considerations that need to be taken into account when designing a trial, including those trials that assess combinations of targets.
Guardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528372/ https://ncbi.nlm.nih.gov/pubmed/22386481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.01.009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|